Immuno-Oncology 2019 is a conference that covers topics such as:
- The recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
- Targeting immune checkpoints with Humabody VH Therapeutics
- Unwanted immunogenicity and functionality testing of immuno-oncology drugs
- The tumour mutation burden and the potential of its use as an indication of treatment choice
- New techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology
Immuno-Oncology 2019 brings together attendees with job titles such as:
- Director of Immunopharmacology
- Professor of Immunochemistry, Oncology, Experimental Immunology, Cancer Medicine and Medicinal Oncology
- Scientist, Tumour Immunology
- Medical Assessor, Biologics Licensing
- Director of Research
- Head of Clinical Analysis
- Head of Immunology
- Consultant in Medical Oncology